SCHEMBL12606367

SCHEMBL12606367

CCn1cc(-c2cc3nccnc3[nH]2)c2cc(OC)ccc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 9/20 0.74
GSK3A P49840 8/20 0.74
IGF1R P08069 3/20 0.74
LCK P06239 2/20 0.74
CDK7 P50613 2/20 0.74
LRRK2 Q5S007 2/20 0.74
AURKB Q96GD4 2/20 0.74
JAK2 O60674 1/20 0.74
BTK Q06187 1/20 0.74
CDK5 Q00535 6/20 0.53
AURKA O14965 1/20 0.53
PAK4 O96013 1/20 0.53
ABL1 P00519 1/20 0.53
NTRK1 P04629 1/20 0.53
FYN P06241 1/20 0.53
CSF1R P07333 1/20 0.53
RET P07949 1/20 0.53
MET P08581 1/20 0.53
PDGFRB P09619 1/20 0.53
PIM1 P11309 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778085 0.88 GSK3B (0.73) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1780099 0.86 GSK3B (0.70) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1778128 0.86 GSK3B (0.70) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1777906 0.86 GSK3B (0.67) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1778596 0.85 GSK3B (1.00) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL12606257 0.85 IGF1R (0.58) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1777901 0.82 GSK3B (0.64) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1779842 0.81 GSK3B (0.62) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL1779102 0.81 KDM4E (0.55) GSK3BGSK3AIGF1RLCKCDK7
SCHEMBL5619401 0.81 GSK3B (0.71) GSK3BGSK3AIGF1RLCKCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 US disclosed
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 US disclosed
EP-2233486-A1 Azaindoles Aventis Pharma Limited (GB) 2010-09-29 EP disclosed